Saturday, October 3, 2026

Silver Bullish Momentum: 0.53% Up Since The Last Session

ViaNews Editorial Team

January 26, 2021

Silver Bullish Momentum: 0.53% Up Since The Last Session

Silver is currently on bullish momentum. At 09:04 EST on Tuesday, 26 January, Silver is at $25.62 and 0.53% up since the last session's close.

Silver Range

Silver is 1.065% up from its last session low of $25.35 and 0.787% up from its last session high of $25.42.

Silver is 1.63% down from its last three sessions higher value of $26.05 and is 2.28% up from its last three sessions lower value of $25.05.

Silver is 1.63% down from its last seven sessions higher value of $26.05 and is 6.57% up from its last seven sessions lower value of $24.04.

Silver is 7.86% down from its last month's higher value of $27.81 and is 6.57% up from its last month's lower value of $24.04.

Volatility

Silver's last day, last week, and last month's average volatility was a negative 0.55%, a positive 0.50%, and a positive 0.63%, respectively.

Silver's last day, last week, and last month's high and low average amplitude percentage was 0.28%, 1.09%, and 1.75%, respectively.

Last news about Silver

Nickel rock completes property expansion targeting lithium clay deposits at silver peak, clayton valley, Nevada. According to Business Insider on Tuesday, 26 January, "This includes Silver Peak, a site uniquely positioned as the only lithium-producing resource in the United States," said Eric Norris, Albemarle President, Lithium. ", "It has been widely reported that Albemarle is planning to double its lithium production by 2025 in Nevada at the Silver Peak mine by committing between US$30 million and US$50 million in additional investment on the property."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com